Sherbrooke Park Advisers’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-7,708
Closed -$973K – 930
2024
Q4
$973K Buy
+7,708
New +$1.15M 0.31% 52
2024
Q1
– Sell
-2,755
Closed -$208K – 995
2023
Q4
$208K Sell
2,755
-6,551
-70% -$415K 0.1% 327
2023
Q3
$613K Buy
+9,306
New +$696K 0.19% 197

Other funds holding THC

Sherbrooke Park Advisers's THC Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of Tenet Healthcare (THC) in Q1 2025, closing a stake of 7,708 shares — an estimated $973K sold.

Sherbrooke Park Advisers first reported a position in THC in Q3 2023 and held it in 3 quarters. The position peaked at $973K in Q4 2024. 567 funds tracked by Wall St. Rank hold THC as of Q1 2025.

  • Sherbrooke Park Advisers reported no remaining Tenet Healthcare position as of Q1 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 7,708 Tenet Healthcare shares in Q1 2025, an estimated $973K.
  • Sherbrooke Park Advisers first reported a position in Tenet Healthcare in Q3 2023 and held it in 3 quarters.
  • Sherbrooke Park Advisers's Tenet Healthcare position peaked at $973K in Q4 2024.
  • 567 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.